canakinumab 治疗镶嵌型肿瘤坏死因子受体相关周期性综合征的疗效.
关键词: Canakinumab Mosaic Somatic mutation TNFRSF1A TRAPS syndrome
Mesh : Female Humans Male Antibodies, Monoclonal / therapeutic use Antibodies, Monoclonal, Humanized / therapeutic use Fever / drug therapy Hereditary Autoinflammatory Diseases / drug therapy Receptors, Tumor Necrosis Factor, Type I / genetics Treatment Outcome Adult Middle Aged
来 源: DOI:10.1016/j.ejim.2024.01.034